Table 3.
Author | Procedure | n | Mean LGP rate (%) | Mean LGP timing (months) | Mean preLGP IOP (mmHg) | Mean postLGP IOP (mmHg) | Reduction in IOP |
---|---|---|---|---|---|---|---|
Khairy et al.18 | DS | 43 | 4.6 | NA | NA | NA | NA |
El Sayyad et al.32 | DS | 39 | 10.3 | 9.6 | NA | NA | 7.4 mmHg |
Shaarawy33 | DS | 52 | 40 | 23.7 | 23.6 | 16.7 | 29% |
Wishart et al.34 | DS | 52 | 19 | 20.6 | 33.5 | 20.6 | 38.5% |
Devloo et al.25 | DS | 69 | 30 | NA | 23.75 | 16 | 29.42% |
Shaarawy & Mermoud26 | DS | 26 | 46 | 13.2 | 19.5 | 14.7 | NA |
Mousa11 | DS + implant | 20 | 45 | NA | NA | NA | NA |
Bissig et al.15 | DS + implant | 105 | 59.8 | 29 | 19.8 | 12 | 39.4% |
Mermoud et al.14 | DS + implant | 100 | 41 | 9.9 | 22.2 | 12.5 | NA |
Shaarawy19 | DS + implant | 105 | 51 | 21 | 20 | 11 | 45% |
Jehn et al.35 | DS + implant | 27 | 30 | NA | NA | NA | NA |
Devloo et al.25 | DS + implant | 24 | 50 | NA | 25.63 | 15.75 | 37.03% |
Shaarawy & Mermoud26 | DS + implant | 26 | 46 | 14.5 | 22 | 7.3 | NA |
Ates et al.36 | DS + implant | 54 | 5.5 | NA | NA | NA | NA |
Drolsum37 | DS + implant | 29 | 44.8 | NA | NA | NA | NA |
Ravinet et al.38 | DS + implant | 22 | 50 | 10 | NA | NA | 5.1 mmHg |
Hamel et al.39 | DS + implant | 21 | 71.4 | NA | 20.3 | 11.5 | 43.3% |
Lachkar et al.27 | DS + implant | 157 | 47.3 | NA | NA | NA | NA |
Ates et al.40 | DS + implant | 23 | 13 | NA | NA | NA | NA |
Mermoud et al.41 | DS + implant | 44 | 23 | 9.1 | 21.0 | 12.0 | NA |
Wevill et al.42 | DS + implant | 17 | 22 | 1 | NA | NA | NA |
Anand and Atherley43 | DS + implant | 19 | 81 | NA | NA | NA | NA |
Anand and Pilling20 | DS + implant ± MMC | 258 | 67 | 10.3 | 19.6 | 14.3 | NA |
Ollikainen et al.24 | DS + implant + MMC | 31a | 29 | NA | 24.4 | 12.9 | NA |
Ollikainen et al.24 | DS + implant + MMC | 37b | 55.6 | NA | 26.2 | 10.6 | |
Anand & Atherley43 | DS + implant + MMC | 52 | 45 | NA | NA | NA | NA |
Mendrinos et al.44 | DS + implant ± MMC | 22 | 63.6 | 16.6 | 21.8 | 9 | NA |
Lachkar et al.27 | DS + 5-FU | 90 | 46.9 | NA | NA | NA | NA |
n: number of eyes in the study; LGP: Laser goniopuncture; IOP: Intraocular pressure; DS: Deep Sclerectomy; MMC: Mitomycin C.
Eyes with primary open angle glaucoma.
Eyes with pseudoexfoliative glaucoma.